摘要
目的探究血脂康胶囊治疗糖尿病性脂肪肝的临床价值。方法选取2012年8月—2015年8月该院收治的糖尿病性脂肪肝患者30例作为观察对象。中心随机法分为2组,实验组15例接受血脂康胶囊治疗,对照组15例接受葡醛内酯片与肌苷片联合治疗,对比2组糖尿病性脂肪肝患者治疗效果的差异性。结果实验组糖尿病性脂肪肝患者治疗的TC水平(5.11±1.03)mmol/L、TG水平(1.55±1.14)mmol/L、ALT水平(22.10±6.20)U/L、以及AST水平(23.14±9.02)U/L均与对照组糖尿病性脂肪肝患者差异有统计学意义(P<0.05)。结论糖尿病性脂肪肝患者接受血脂康胶囊治疗的临床价值较高,可改善患者的血清学指标。
Objective To explore the clinical value of： capsule in treatment of diabetic fatty liver. Methods Select August 2012-August 2012 our hospital 30 cases of patients with diabetic fatty liver as research object. Center randomized divided into 2 groups, experimental group： capsule treated 15 cases, 15 cases were accepted the Portuguese aldehyde lactone and i-nosine pills combined treatment, compared two groups differences of diabetes patients with fatty liver treatment effect. Re-sults In experimental diabetic fatty liver patients TC level （5.11±1.03） mmol/L, TG level （1.55±1.14） mmol/L,levels （22.10±6.20） U/L, and AST level （23.14±9.02） U/L was a significant difference was found in patients with diabetic fatty liver to control group （P〈0.05）. Conclusion Capsule treated diabetes patients with fatty liver the clinical value of high, serological indexes in patients can be improved.
出处
《糖尿病新世界》
2016年第13期5-6,共2页
Diabetes New World Magazine
